<DOC>
	<DOCNO>NCT02378220</DOCNO>
	<brief_summary>Patients meet eligibility criterion randomize two group , one receiving pharmacogenetic test receive pharmacogenetic testing . In open-label trial , pharmacist make medication therapy recommendation use YouScript® Personalized Prescribing System patient receive genetic test standard drug information resource per usual patient undergo pharmacogenetic testing .</brief_summary>
	<brief_title>Pharmacogenetic Testing Among Home Health Patients</brief_title>
	<detailed_description>Both group follow 60 day . The number re-hospitalizations emergency department ( ED ) visit record well time first re-hospitalization time first ED visit . Select OASIS metric ( e.g . M1034 , M1242 , M1710 , M1720 , M1745 , M2110 ) PHQ-2 evaluate documented time admission home health , 30 day , 60 day improvement overall status , pain , confusion , anxiety , depression , disruptive behavior , need assistance activity daily live ( ADLs ) instrumental activity daily live ( IADLs ) . The number fall collect well proportion YouScript® recommendation accept study pharmacist pass clinician proportion recommendation accept clinician .</detailed_description>
	<mesh_term>Drug-Related Side Effects Adverse Reactions</mesh_term>
	<mesh_term>Metabolism , Inborn Errors</mesh_term>
	<criteria>Age 50 older . Willing able provide inform consent study participation either directly legally authorize representative ( LAR ) . Presently take begin treatment least one follow oral form medication ( exclude medication take PRN ) ( generic name give major U.S. brand name give parenthesis ) . These medication subject significant druggene interaction define FDA box warn , FDA cautionary labeling , clinical literature YouScript® algorithmpredicted significant effect : Amitriptyline ( Elavil ) , Aripiprazole ( Abilify ) , Atomoxetine ( Strattera ) , Carvedilol ( Coreg ) , Celecoxib ( Celebrex ) , Citalopram ( Celexa ) , Clobazam ( Onfi ) , Clomipramine ( Anafranil ) , Clopidogrel ( Plavix ) , Clozapine ( Clozaril ) , Codeine [ Tylenol # 3 ( combo ) ] , Desipramine ( Norpramin ) , Dextromethorphan ( Delsym ) , Diazepam ( Valium ) , Doxepin ( Sinequan ) , Escitalopram ( Lexapro ) , Esomeprazole ( Nexium ) , Fesoterodine ( Toviaz ) , Flecainide ( Tambocor ) , Fluoxetine ( Prozac ) , Flurbiprofen ( Ansaid ) , Fluvoxamine ( Luvox ) , Haloperidol ( Haldol ) , Hydrocodone , Ibuprofen ( Motrin ) , Iloperidone ( Fanapt ) , Imipramine ( Tofranil ) , Indomethacin ( Indocin ) , Meloxicam ( Mobic ) , Metoprolol ( Toprol XL ) , Mexiletine ( Mexitil ) , Nortriptyline ( Pamelor ) , Omeprazole ( Prilosec ) , Oxycodone ( Oxycontin ) , Paroxetine ( Paxil ) , Perphenazine ( Trilafon ) , Phenobarbital ( Luminal ) , Phenytoin ( Dilantin ) , Pimozide ( Orap ) , Piroxicam ( Feldene ) , Proguanil [ ( Malarone ( combo ) ] , Propafenone ( Rythmol ) , Propranolol ( Inderal ) , Risperidone ( Risperdal ) , Sertraline ( Zoloft ) , Tetrabenazine ( Xenazine ) , Thioridazine ( Mellaril ) , Timolol ( Apotimol ) , Tolterodine ( Detrol ) , Torsemide ( Demadex ) , Tramadol ( Ultram ) , Trimipramine ( Surmontil ) , Venlafaxine ( Effexor ) , Voriconazole ( Vfend ) , Vortioxetine ( Brintellix ) , Warfarin ( Coumadin ) . Previous CYP testing ( CPT cod 81225 , 81226 , 81227 , 81355 , 81401 ) History organ transplant ( 199.2 ; 238.77 ; 414.06 ; 414.07 ; 996.80996.89 ; E878.0 ; V42.0V42.7 ; V42.81V42.84 ; V42.89 ; V42.9 ; V45.87 ; V49.83 ; V58.44 ) Current malabsorption syndrome ( 579.0 ) , include follow : Intestinal malabsorption ( 579.8 , 579.9 ) , Postoperative malabsorption ( 579.3 ) , Short bowel syndrome ( 579.3 ) Treatment invasive solid tumor hematologic malignancy last year , exclude situ cancer nonmelanoma skin cancer ( basal cell carcinoma ) End Stage Renal Disease ( ESRD ) Persistent acute renal failure : complete loss kidney function &gt; 4 week ( require dialysis ) Renal failure : Glomerular filtration rater ( GFR ) : SCr &gt; 3 time baseline GFR decrease 75 % SCr ≥4 mg/dL ; acute rise ≥0.5 mg/dL ; OR Urine Output ( UO ) : UO &lt; 0.3 mL/kg/h 24 h ( oliguria ) anuria 12 h .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Home Care Agencies</keyword>
	<keyword>Home Health Care Agencies</keyword>
	<keyword>Home Health Care Nursing</keyword>
	<keyword>Home Health Nurses</keyword>
	<keyword>CYP 2D6</keyword>
	<keyword>CYP 2C9</keyword>
	<keyword>CYP 2C19</keyword>
	<keyword>CYP 3A4</keyword>
	<keyword>CYP 3A5</keyword>
</DOC>